Medicine Description vincristine 5mg
Vincristine 5mg Vial is a medication that belongs to the class of vinca alkaloids, derived from the periwinkle plant. Its primary mechanism of action involves the inhibition of microtubule formation during cell division, specifically targeting the mitotic spindle during metaphase. This disruption prevents the proper segregation of chromosomes, ultimately leading to cell cycle arrest and apoptosis of rapidly dividing cancer cells. By interfering with the assembly and disassembly of tubulin, vincristine effectively halts the proliferation of tumor cells, making it a vital component in the treatment regimens for various hematologic malignancies and solid tumors.
Indications and Uses of Vincristine 5mg Vial
- Acute Lymphoblastic Leukemia (ALL)
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma
- Wilms Tumor
- Neuroblastoma
- Other pediatric malignancies
Side Effects of Vincristine 5mg Vial
- Neuropathy (numbness, tingling, or weakness)
- Constipation
- Alopecia (hair loss)
- Febrile neutropenia
- Thrombocytopenia (low platelet count)
- Extravasation injury at the injection site
Storage and Handling
Store Vincristine 5mg Vial at controlled room temperature, away from light and moisture. Protect from freezing. Once reconstituted, it should be used immediately or stored in a refrigerator and used within a specified period as directed by a healthcare professional.
Patient Advice and Precautions
Patients should be counseled on the risk of peripheral neuropathy and advised to report any unusual symptoms, such as numbness or tingling. Regular blood tests are essential to monitor blood cell counts and liver function. Avoid live vaccines during treatment and consult healthcare providers before starting any new medications. Pregnant women or those planning to become pregnant should inform their healthcare provider, as vincristine is contraindicated in pregnancy.